BC008-1A

· Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BC008-1A, covering 2025-07-09 to 2025-07-09. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of BC008-1A Injection in Patients With Advanced Solid Tumors [Phase 1]